Standout Papers

Lead Time and Overdiagnos... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
    2009 575 citations Gerrit Draisma, Ruth Etzioni et al. JNCI Journal of the National Cancer Institute profile →

Immediate Impact

5 from Science/Nature 104 hit
Sub-graph 1 of 19

Citing Papers

Screening for Prostate Cancer
2023 Hit
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
2022 Hit
19 intermediate papers

Works of R. Gulati being referenced

Individualized Estimates of Overdiagnosis in Screen-Detected Prostate Cancer
2014
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
2009 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Gulati 454 229 103 99 85 4 614
Dante diTommaso 330 0.7× 153 0.7× 73 0.7× 142 1.4× 47 0.6× 7 529
Thomas H. Douglas 414 0.9× 129 0.6× 65 0.6× 81 0.8× 70 0.8× 12 506
Elisabeth M. Wever 399 0.9× 219 1.0× 84 0.8× 46 0.5× 63 0.7× 11 533
Charles R. Sherman 221 0.5× 222 1.0× 207 2.0× 81 0.8× 80 0.9× 6 632
Taryn Stoffs 232 0.5× 208 0.9× 72 0.7× 120 1.2× 74 0.9× 7 526
Manfred Wirth 351 0.8× 115 0.5× 127 1.2× 68 0.7× 49 0.6× 7 512
Malcolm Mason 432 1.0× 144 0.6× 257 2.5× 80 0.8× 76 0.9× 14 683
Alphonsus C. M. van den Bergh 618 1.4× 87 0.4× 84 0.8× 29 0.3× 80 0.9× 4 666
Raphael Pfeffer 620 1.4× 71 0.3× 86 0.8× 30 0.3× 74 0.9× 5 659
Gunna Aus 569 1.3× 106 0.5× 113 1.1× 45 0.5× 52 0.6× 8 653

All Works

Loading papers...

Rankless by CCL
2026